Arlene
Medical Assistant
More information coming soon!
Medical Assistant
More information coming soon!
Lead Aesthetician
Christine is a California Board Certified Aesthetician. She has over 10 years of experience in the medical skincare industry with an extensive background in acne and skincare. Christine has advanced training in treatments such as chemical peels, microdermabrasion, and Hydrafacial MD. Educating patients and having a warm understanding of their needs has always been the focus of her career.
Patient Coordinator
More information coming soon!
Medical Assistant
More information coming soon!
Patient billing liaison
With Kari’s ability to efficiently carry out the demands of our busy and diverse patient base she is dedicated to coordinating all of your insurance needs while providing you with excellent service and care along the way.
Patient Coordinator
More information coming soon!
Patient Satisfaction Liaison
More information coming soon!
Aesthetician
More information coming soon!
Practice Manager
As our practice manager, Monica coordinates all patient related functions, business operations, public relations, sales and marketing efforts. Her creativity and leadership skills have greatly contributed to the growth and success of the Dermatology Institute of Southern California. She works alongside Dr. Behroozan as a trusted and valued extension, for all patient issues.
Medical Assistant
More information coming soon!
Medical Assistant
With her extensive knowledge and a personable approach, Priscilla brings over 6 years of dermatology experience to our office. Priscilla thrives in delivering compassionate care in an efficient manner. Her outstanding ability to connect with patients ensures maximum comfort and trust whilst in our care.
Scheduler
More information coming soon!
A link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided for informational purposes only. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.